Due to the limited occurrence of SET-NUP214, with the reporting occurrence varying from 4.9 to 6% in T-ALL (5, 6), the outcome of acute leukemia patients with SET-NUP214 after hematopoietic stem cell transplantation has rarely been reported. This evidence concerns the gene NUP214 and acute lymphoblastic leukemia.